Invention Grant
US08741967B2 Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer
有权
使用不饱和鞘氨醇化合物作为治疗癌症的化学治疗剂
- Patent Title: Use of unsaturated sphingosine compounds as chemotherapeutic agents for the treatment of cancer
- Patent Title (中): 使用不饱和鞘氨醇化合物作为治疗癌症的化学治疗剂
-
Application No.: US12747253Application Date: 2008-12-12
-
Publication No.: US08741967B2Publication Date: 2014-06-03
- Inventor: Julie D. Saba , Henrik Fyrst , Robert Bittman
- Applicant: Julie D. Saba , Henrik Fyrst , Robert Bittman
- Applicant Address: US CA Oakland US NY New York
- Assignee: Children's Hospital & Research Center at Oakland,Research Foundation of the City University of New York
- Current Assignee: Children's Hospital & Research Center at Oakland,Research Foundation of the City University of New York
- Current Assignee Address: US CA Oakland US NY New York
- Agency: Seed IP Law Group PLLC
- International Application: PCT/US2008/086581 WO 20081212
- International Announcement: WO2009/076598 WO 20090618
- Main IPC: A61K8/68
- IPC: A61K8/68 ; A61K31/133
Abstract:
The present invention is directed to unsaturated sphingosine compounds which are useful as therapeutic agents for the treatment of cancer and for the treatment of other diseases including diabetes and infection with intracellular bacteria. This invention is also directed to methods of using the compounds and pharmaceutical compositions comprising the compounds in treating these diseases.
Public/Granted literature
- US20110098317A1 USE OF UNSATURATED SPHINGOSINE COMPOUNDS AS CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER Public/Granted day:2011-04-28
Information query
